🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the efficacy and safety of long...
Status
Completed
Location
Kameda Medical Center
Start Date
2018-02-18
Trial ID
NCT03416374
Treatments Being Tested
The main objective of this study is to evaluate the minimal residual diseas...
Status
Unknown
Location
CHU Bordeaux
Start Date
2018-12-31
Trial ID
NCT03669445
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
The main aim is to show that long-term use of ixazomib can improve symptoms...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-06-30
Trial ID
NCT05183139
Treatments Being Tested
This study will independently assess the efficacy and safety of 11 combinat...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2015-10
Trial ID
NCT02343042
This research study is evaluating a new drug called "ixazomib" as a possibl...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10
Trial ID
NCT02916771
Treatments Being Tested
This study is the first study of tasquinimod, an inhibitor of S100A9, in pa...
Status
Terminated
Location
University of Pennsylvania
Start Date
2020-07-10
Trial ID
NCT04405167
Treatments Being Tested
The goal of this clinical research study is to evaluate the safety and effe...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2014-09
Trial ID
NCT02206425
Treatments Being Tested
This is a phase II, multicenter, open-label study to evaluate the safety an...
Status
Completed
Location
CHRU - Hôpital du Haut Lévêque
Start Date
2014-11-12
Trial ID
NCT01936532
Treatments Being Tested
A Phase 1/2a study to assess the safety, tolerability, PK and biological ac...
Status
Recruiting
Location
Emory Winship Cancer Institute
Start Date
2019-08-09
Trial ID
NCT04068597